Amylyx Pharmaceuticals, Inc.

AMLXCIK 0001658551 · Every Form 4 filed by insiders at this issuer.

Filings

16

Latest Mar 15, 2024

Unique insiders

7

Showing

16 of 16

Page 1

Top insiders

Most active reporters at Amylyx Pharmaceuticals, Inc.

NameRolesFilings
Cohen Joshua B
OfficerDirector
3
FRATES JAMES M
Officer
3
Klee Justin B.
OfficerDirector
3
Mazzariello Gina
Officer
3
MILNE GEORGE M JR
Director
2
Yeramian Patrick D
Officer
1
Zeiher Bernhardt G
Director
1

All filings

16 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 15, 2024
Zeiher Bernhardt G
Director
Holdings only
Mar 7, 2024
FRATES JAMES M
Chief Financial Officer
S1,792$18.7279$33,560
Mar 7, 2024
Mazzariello Gina
Chief Legal Officer
S1,540$18.7279$28,841
Mar 7, 2024
Klee Justin B.
Co-Chief Executive Officer · Director
S4,135$18.7279$77,440
Mar 7, 2024
Cohen Joshua B
Co-Chief Executive Officer · Director
S4,135$18.7279$77,440
Feb 28, 2024
Mazzariello Gina
Chief Legal Officer
A36,667$0.00$0
Feb 28, 2024
Klee Justin B.
Co-Chief Executive Officer · Director
A126,667$0.00$0
Feb 28, 2024
Cohen Joshua B
Co-Chief Executive Officer · Director
A126,667$0.00$0
Feb 28, 2024
FRATES JAMES M
Chief Financial Officer
A40,000$0.00$0
Feb 27, 2024
Mazzariello Gina
Chief Legal Officer
S2,838$18.7564$53,231
Jan 29, 2024
MILNE GEORGE M JR
Director
G9,100$0.00$0
Jan 18, 2024
MILNE GEORGE M JR
Director
G94,350$0.00$0
Jan 11, 2024
Yeramian Patrick D
Chief Medical Officer
S2,812$16.3281$45,915
Jan 11, 2024
Cohen Joshua B
Co-Chief Executive Officer · Director
S5,841$16.3281$95,372
Jan 11, 2024
FRATES JAMES M
Chief Financial Officer
S2,716$16.3281$44,347
Jan 11, 2024
Klee Justin B.
Co-Chief Executive Officer · Director
S5,841$16.3281$95,372

Showing 116 of 16

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.